Context: The homeostatic model assessment of insulin resistance (HOMA-IR) and triglyceride (TG)/ high-density lipoprotein cholesterol (HDL-C) ratio (TG/HDL-C) are insulin resistance indexes routinely used in clinical and population-based studies; however, their short-term repeatability is not well characterized.
implementation is difficult in large, population-based studies because of its invasive, time-consuming, and costly protocol. As a result, insulin resistance indexes are routinely used as insulin resistance proxy indicators in clinical and population-based studies.
Insulin resistance indexes are based on common analytes that reflect different aspects of insulin resistance. The homeostatic model assessment of insulin resistance (HOMA-IR) reflects dysregulation of fasting glucose and insulin; it is strongly correlated with direct measures of insulin-mediated glucose uptake (r = 20.82) (5) . The triglyceride (TG)/ high-density lipoprotein cholesterol (HDL-C) ratio (TG/HDL-C) reflects the dyslipidemia seen in insulin resistance; it is strongly correlated with direct measures of insulin-mediated glucose uptake (r = 0.60) and is more correlated with these measures than either TG (r = 0.57) or HDL-C is individually (r = 20.40) (6) . Both insulin resistance indexes are minimally invasive and commonly used in research. However, although insulin assays are not well standardized, plasma TG and HDL-C assays are well standardized and widely used in research as well as in clinical settings (7) (8) (9) (10) (11) (12) .
The short-term repeatability of insulin resistance indexes has not been well characterized, which hinders their interpretation in exposure-outcome associations (13, 14) . We thus quantified and compared the shortterm repeatability of commonly used insulin resistance indexes and their constituent analytes-consisting of fasting glucose and insulin for HOMA-IR and TG and HDL-C for TG/HDL-C-in a community-based population of older adults.
Materials and Methods

Study population
The Atherosclerosis Risk in Communities (ARIC) Study is an ongoing prospective study of 15,792 adults 45 to 64 years old from four US communities (Washington County, Maryland; Forsyth County, North Carolina; Jackson, Mississippi; and the northwestern suburbs of Minneapolis, Minnesota) (15) . Complete examinations were conducted in 1987 to 1989 (visit 1), 1990 to 1992 (visit 2), 1993 to 1995 (visit 3), 1996 to 1998 (visit 4), and 2011 to 2013 (visit 5). Before all examinations, participants were asked to fast for 8 hours, to bring in medications taken within the past 2 weeks, and to refrain from smoking and vigorous physical activity at least 1 hour before the examination. Institutional review boards at each site reviewed the study, and written informed consent was obtained from all participants.
A repeatability study was conducted to include an initial examination and a repeated examination scheduled 4 to 8 weeks later following the same standardized protocol (16) . Participants were recruited in the order of arrival at the initial examination (visit 5; 2011 to 2013). The study sample included 200 participants. Our analytic sample included 102 participants after exclusions for (1) diabetes, defined by fasting glucose level $126 mg/dL (7 mmol/L), nonfasting glucose level $200 mg/dL (11.1 mmol/L), or use of diabetes medications (n = 65); (2) missing diabetes status (n = 6); (3) fasting for ,8 hours at either examination (n = 9); (4) missing measurements at either examination (n = 11); and (5) measurements .3 standard deviations (SDs) from the mean at either examination (n = 7).
Blood collection, processing, and assays
The standardized protocol used for specimen collection, processing, shipping, and assay was the same at all examinations. Blood samples were collected by trained staff following a standard venipuncture protocol, processed within 90 minutes, and shipped weekly to the Atherosclerosis Clinical Research Laboratory at the Baylor College of Medicine. The central laboratory was masked; bar code ID labels on blood specimens for the regular examinations and repeated examination were indistinguishable (17 
Insulin resistance indexes and their constituent analytes
We calculated HOMA-IR, equal to the product of insulin in mU/mL and fasting glucose in mg/dL divided by 405 (9) . Insulin and fasting glucose were assayed using a radioimmunoassay method (Cobas e411; Roche) and an enzymatic method (Olympus AU480; Beckman/Olympus), respectively (18) . We calculated TG/HDL-C, equal to the ratio of TG in mg/dL to HDL-C in mg/dL (10) . TG and HDL-C were assayed using an enzymatic method (Olympus AU480; Beckman/Olympus) and a direct method (Olympus AU480; Beckman/Olympus), respectively (18) .
Statistical analysis
We calculated summary statistics to describe measurements at both examinations. We also generated Bland-Altman plots to compare measurements at both examinations.
We used linear mixed-effects models to partition total variance (s 2 total ) into between-person variance (s 2 bp ) and withinperson variance (s 2 wp ). We quantified repeatability using the intraclass correlation coefficient (ICC), given by
and the within-person CV, given by
where m = mean of measurements at both examinations. Suggested benchmarks for ICC were defined as follows: poor (0 to 0.39), fair to good (0.40 to 0.75), and excellent (0.76 to 1) (19).
We calculated the minimum detectable change with 95% confidence (MDC 95 ) for a one-sample study design to describe true change beyond measurement error, equal to:
where
SEM being the standard error of measurement (20, 21) . We calculated the minimum detectable difference with 95% confidence (MDD 95 ) for a two-sample study design to describe true difference beyond measurement error, equal to: where df represents degrees of freedom. We also calculated the MDC 95 and MDD 95 as a percentage of the grand mean. Additional analyses were conducted. We quantified the repeatability of the insulin resistance indexes and their analytes after log transformation. We quantified the repeatability of the insulin resistance indexes and their analytes including measurements .3 SDs from the mean at each examination. We quantified the repeatability of the lipid-based insulin resistance index and its constituent analytes after excluding adults with statin use 4 weeks before the initial examination.
Results
Mean age was 76 years, 68% of participants were female (n = 69), and 24% were African American (n = 24). Mean waist circumference was 99 cm. Mean time between measurements was 46 days (range, 28 to 102 days). See Table 1 for the distribution of the measurements at each examination.
For HOMA-IR, insulin, and fasting glucose, the ICCs were 0.70, 0.68, and 0.70, respectively; between-person variance contributed a majority to total variance. For TG/HDL-C, TG, and HDL-C, the ICCs were 0.80, 0.68, and 0.91, respectively; between-person variance contributed a majority to total variance. Repeatability was higher for TG/HDL-C than for HOMA-IR (ICC, 0.80 vs 0.70) ( Table 2) .
Within-person CVs for HOMA-IR, insulin, and fasting glucose were 30.4%, 28.8%, and 5.6%, respectively; dispersion was greater for insulin. Withinperson CVs for TG/HDL-C, TG, and HDL-C were 23.0%, 20.6%, and 8.2%, respectively; dispersion was greater for TG. Dispersion for TG/HDL-C was lower than dispersion for HOMA-IR (CV, 23.0% vs 30.4%) ( Table 2) .
In this community-based sample of older adults, the MDC 95 for HOMA-IR was 2.3, for insulin was 8.4 mU/mL (58.3 pmol/L), and for fasting glucose was 15.7 mg/dL (0.9 mmol/L), representing respective Abbreviations: P5, 5th percentile; P95, 95th percentile. Table 2 ). For a study of N = 100 in each of two samples, a mean difference ,0.8 for HOMA-IR, ,2.8 mU/mL for insulin (19.4 pmol/L), and ,5.3 mg/dL (0.3 mg/dL) for fasting glucose was attributable to measurement error; the corresponding percentage differences between two samples were 28.4%, 26.2%, and 5.2% (Fig. 1) . A mean difference ,0.6 for TG/HDL-C, ,20.5 mg/dL (0.2 mmol/L) for TG, and ,7.9 mg/dL (0.2 mmol/L) for HDL-C was attributable to measurement error; the corresponding percentage differences between two samples were 26.4%, 18.8%, and 14.4% (Fig. 2) . The detectable percentage difference was somewhat lower for TG/HDL-C than for HOMA-IR (percentage difference, 26.4% vs 28.4%).
We quantified the repeatability of the insulin resistance indexes and their analytes after log transformation, motivated by skew in their distribution, as well as higher differences at higher mean levels of measurements ( Figs Table 1 ). Because the ICCs were similar before and after log transformation, our main results were presented in the original units.
In our main analyses, we excluded measurements .3 SDs from the mean at each examination (n = 7). To gauge their influence, we quantified the repeatability of the insulin resistance indexes and their constituent analytes including all observations. The replicate measurements for the outliers across the two examinations were not consistent, as indicated by the differences in measurements between the Figure 1 . Minimum detectable difference (MDD 95 ) of (A) insulin resistance index HOMA-IR and constituent analytes, (B) insulin, and (C) fasting glucose in a short-term repeatability study of adults 68 to 88 years old (n = 102) in the ARIC Study (2011 to 2013). Sample sizes per group were 5, 10, 50, 100, 500, and 1000. Grand mean for HOMA-IR was 2.7, for insulin was 10.5 mU/mL, and for fasting glucose was 101.1 mg/dL. Conversion factors: insulin (1 pmol/L = 0.14 mU/mL); fasting glucose (1 mmol/L = 18 mg/dL). two examinations (Supplemental Figs. 5 and 6 ). Including outliers, the ICCs for HOMA-IR, insulin, and fasting glucose were 0.77, 0.77, and 0.56, respectively. Including outliers, the ICCs for TG/HDL-C, TG, and HDL-C were 0.81, 0.76, and 0.92, respectively. Thus, consistent with our main results, repeatability was somewhat higher for TG/HDL-C than for HOMA-IR (ICC, 0.81 vs 0.77) ( Table 2) .
We quantified the repeatability of TG/HDL-C, TG, and HDL-C after excluding statin use. Mean TG/HDL-C, TG, and HDL-C levels did not differ by statin use (Supplemental Table 2 ). The ICCs in adults without statin use for TG/HDL-C, TG, and HDL-C were 0.79, 0.63, and 0.91, respectively. Thus, short-term repeatability of the latter in adults without statin use (n = 52) did not differ from our main finding in all adults (n = 102) (Supplemental Table 3 ).
Discussion
In a community-based population of older adults, the short-term repeatability was fair to good for HOMA-IR and excellent for TG/HDL-C according to suggested benchmarks (19) . The short-term repeatability of the indexes was consistent with the short-term repeatability of their respective analytes (mean, 46 days; range, 28 to 102 days).
Given its formulation, we interpreted our findings in the context of our study population (22) . We recognize that participants who attend a study may differ in general from participants who do not attend a study. We endeavored to ensure internal validity by recruiting participants at random, by implementing a standardized protocol, and by using exclusion criteria that could affect measurement accuracy. As such, our findings represent the intraindividual variability of the insulin resistance indexes among free-living older adults without diabetes.
Short-term repeatability for insulin, fasting glucose, TG, and HDL-C has been reported in prior studies. In adults 45 to 64 years old examined 1 to 2 weeks apart (n = 40), the ICC for insulin was 0.81, for fasting glucose was 0.84, for TG was 0.85, and for HDL-C was 0.94 (22, 23) . Our results inform the use of insulin resistance indexes in clinical and population-based research. Adding new information, we characterized the short-term repeatability of a glucose and insulin-based index, as well as the short-term repeatability of an alternative TG and HDL-C-based index that circumvents well-known issues with insulin assays and standardization. We calculated the MDC 95 and MDD 95 for each index, which can be used to inform future one-sample study designs (e.g., longitudinal studies with repeated measurements) and two-sample study designs (e.g., clinical studies with an intervention), respectively.
As a limitation to consider, although participants agreed to fast following a late snack on the night before the examination, fasting time ($8 hours before venipuncture) was self-reported. In an attempt to address this issue, participants were excluded for measurements .3 SDs from the mean at either examination.
In summary, short-term repeatability was fair to good for HOMA-IR and excellent for TG/HDL-C according to suggested benchmarks, reflecting the short-term variability of their constituent analytes (mean, 46 days; range, 28 to 102 days). These measurement properties can inform the use of such metrics in clinical and population-based studies.
